Abpro (NASDAQ:ABP) Research Coverage Started at Maxim Group

Maxim Group began coverage on shares of Abpro (NASDAQ:ABP) in a research report sent to investors on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $4.00 price target on the stock.

Abpro Price Performance

Shares of NASDAQ ABP opened at $0.66 on Monday. Abpro has a 1-year low of $0.65 and a 1-year high of $13.00. The stock’s fifty day moving average is $1.39.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Jane Street Group LLC purchased a new stake in shares of Abpro during the 4th quarter valued at $37,000. Geode Capital Management LLC acquired a new stake in Abpro in the fourth quarter worth about $53,000. LMR Partners LLP purchased a new stake in shares of Abpro during the fourth quarter worth about $112,000. AQR Arbitrage LLC acquired a new position in shares of Abpro during the fourth quarter valued at about $157,000. Finally, Atlas Merchant Capital LLC purchased a new position in shares of Abpro in the 4th quarter valued at approximately $157,000. Institutional investors own 23.30% of the company’s stock.

Abpro Company Profile

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.